优化慢性淋巴细胞白血病的治疗
Optimizing Treatment of Chronic Lymphocytic Leukemia.
作者信息
Kurtin Sandra E
机构信息
The University of Arizona Cancer Center, Tucson, Arizona.
出版信息
J Adv Pract Oncol. 2021 Apr;12(3):325-328. doi: 10.6004/jadpro.2021.12.3.23. Epub 2021 Apr 1.
Abstract
During JADPRO Live Virtual 2020, Sandra Kurtin, PhD, ANP-C, AOCN®, described personalization of the treatment of chronic lymphocytic leukemia (CLL) using molecular attributes of the disease, as well as patient characteristics. Dr. Kurtin discussed front-line treatment in previously untreated patients, treatment for relapsed or refractory CLL, and how to prevent, mitigate, and manage adverse events in order to optimize treatment.
摘要
在2020年JADPRO现场虚拟会议期间，医学博士、高级执业护士、肿瘤护理认证专家桑德拉·库尔廷介绍了如何利用慢性淋巴细胞白血病（CLL）的分子特征以及患者特征对其治疗进行个性化。库尔廷博士讨论了既往未接受治疗患者的一线治疗、复发或难治性CLL的治疗，以及如何预防、减轻和管理不良事件以优化治疗。
相似文献
1
Optimizing Treatment of Chronic Lymphocytic Leukemia.优化慢性淋巴细胞白血病的治疗
J Adv Pract Oncol. 2021 Apr;12(3):325-328. doi: 10.6004/jadpro.2021.12.3.23. Epub 2021 Apr 1.
2
Risk Assessment and Risk-Adapted Treatment Selection: A Case-Based Approach for Chronic Lymphocytic Leukemia.风险评估与风险适应性治疗选择：慢性淋巴细胞白血病的病例分析方法
J Adv Pract Oncol. 2017 Jul-Aug;8(5):502-520. Epub 2017 Jul 1.
3
Biomarker Jeopardy.生物标志物的风险
J Adv Pract Oncol. 2021 Apr;12(3):285-288. doi: 10.6004/jadpro.2021.12.3.13. Epub 2021 Apr 1.
4
Integrating Emerging Data Into Clinical Practice: A Case-Based Approach for Multiple Myeloma.将新兴数据整合到临床实践中：一种针对多发性骨髓瘤的基于病例的方法。
J Adv Pract Oncol. 2017 May-Jun;8(4):365-377. Epub 2017 May 1.
5
Use of Diagnostic Tests in Advanced Non-Small Cell Lung Cancer.诊断测试在晚期非小细胞肺癌中的应用
J Adv Pract Oncol. 2017 Mar;8(2):173-185. doi: 10.6004/jadpro.2017.8.2.5. Epub 2017 Mar 1.
6
Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial.伊布替尼用于既往未治疗及复发或难治的伴有TP53畸变的慢性淋巴细胞白血病：一项2期单臂试验
Lancet Oncol. 2015 Feb;16(2):169-76. doi: 10.1016/S1470-2045(14)71182-9. Epub 2014 Dec 31.
7
Biomarker Jeopardy.生物标志物的风险
J Adv Pract Oncol. 2022 Apr;13(3):292-297. doi: 10.6004/jadpro.2022.13.3.22. Epub 2022 May 23.
8
Diagnosis and Treatment of AL and ATTR Amyloidosis.AL型和ATTR型淀粉样变性的诊断与治疗
J Adv Pract Oncol. 2021 Apr;12(3):329-332. doi: 10.6004/jadpro.2021.12.3.24. Epub 2021 Apr 1.
9
Evaluation of the CLL-IPI in relapsed and refractory chronic lymphocytic leukemia in idelalisib phase-3 trials.在伊布替尼 3 期临床试验中评估复发/难治性慢性淋巴细胞白血病的 CLL-IPI。
Leuk Lymphoma. 2019 Jun;60(6):1438-1446. doi: 10.1080/10428194.2018.1540782. Epub 2018 Nov 8.
10
Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study.抗 CD79B 抗体药物偶联物 polatuzumab vedotin 在复发或难治性 B 细胞非霍奇金淋巴瘤和慢性淋巴细胞白血病中的安全性和活性：一项 1 期研究。
Lancet Oncol. 2015 Jun;16(6):704-15. doi: 10.1016/S1470-2045(15)70128-2. Epub 2015 Apr 27.
本文引用的文献
1
Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment.慢性淋巴细胞白血病：2020 年诊断、风险分层和治疗更新。
Am J Hematol. 2019 Nov;94(11):1266-1287. doi: 10.1002/ajh.25595. Epub 2019 Oct 4.
2
Risk Assessment and Risk-Adapted Treatment Selection: A Case-Based Approach for Chronic Lymphocytic Leukemia.风险评估与风险适应性治疗选择：慢性淋巴细胞白血病的病例分析方法
J Adv Pract Oncol. 2017 Jul-Aug;8(5):502-520. Epub 2017 Jul 1.
3
Integrating Emerging Data Into Clinical Practice: A Case-Based Approach for Multiple Myeloma.将新兴数据整合到临床实践中：一种针对多发性骨髓瘤的基于病例的方法。
J Adv Pract Oncol. 2017 May-Jun;8(4):365-377. Epub 2017 May 1.
4
Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment.慢性淋巴细胞白血病：2015 年诊断、风险分层和治疗更新。
Am J Hematol. 2015 May;90(5):446-60. doi: 10.1002/ajh.23979.
5
Prognostic factors in chronic lymphocytic leukemia-what do we need to know?慢性淋巴细胞白血病的预后因素——我们需要了解哪些？
Nat Rev Clin Oncol. 2011 Jan;8(1):38-47. doi: 10.1038/nrclinonc.2010.167. Epub 2010 Oct 19.
6
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.慢性淋巴细胞白血病诊断与治疗指南：慢性淋巴细胞白血病国际研讨会报告，更新美国国立癌症研究所工作组1996年指南
Blood. 2008 Jun 15;111(12):5446-56. doi: 10.1182/blood-2007-06-093906. Epub 2008 Jan 23.
Zotero 插件